Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
39.73
+0.58 (1.48%)
At close: Dec 5, 2025, 4:00 PM EST
39.85
+0.12 (0.30%)
After-hours: Dec 5, 2025, 7:47 PM EST
Royalty Pharma Market Cap
Royalty Pharma has a market cap or net worth of $22.93 billion as of December 5, 2025. Its market cap has increased by 98.45% in one year.
Market Cap
22.93B
Enterprise Value
30.94B
1-Year Change
98.45%
Ranking
Category
Stock Price
$39.73
Market Cap Chart
Since June 16, 2020, Royalty Pharma's market cap has increased from $15.76B to $22.93B, an increase of 45.51%. That is a compound annual growth rate of 7.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 16.97B | 49.76% |
| Dec 31, 2024 | 11.33B | -9.30% |
| Dec 29, 2023 | 12.50B | -28.31% |
| Dec 30, 2022 | 17.43B | 1.85% |
| Dec 31, 2021 | 17.12B | -11.89% |
| Dec 31, 2020 | 19.43B | 23.26% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 936.68B |
| Johnson & Johnson | 494.92B |
| AbbVie | 396.55B |
| UnitedHealth Group | 293.98B |
| AstraZeneca | 282.37B |
| Novartis AG | 253.36B |
| Merck & Co. | 250.76B |
| Abbott Laboratories | 219.65B |